Patent · US Active

Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptides

US9458235B2 · kind B2 · utility

2Cited by

0References

2Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Sanjaya Singh · Sandy Hook, US
Alisa K. Waterman · Weston, US
Erik Depla · Laarne, BE
Toon Laeremans · Dworp, BE
Diane Van Hoorick · Laarne, BE
Cedric Jozef Neotere Ververken · Merelbeke, BE

Key dates

Filing date	Apr 9, 2015
Grant date	Oct 4, 2016
Priority date	—
Expiry date	Apr 9, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to CX3CR1-binding polypeptides, in particular polypeptides comprising specific immunoglobulin domains. The invention also relates to nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to host cells expressing or capable of expressing such polypeptides; to compositions comprising such polypeptides; and to uses of such polypeptides or such compositions, in particular for prophylactic, therapeutic and diagnostic purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.